bioRxivMolecular BiologyPreprint
A comprehensive dataset of TLX1 positive ALL-SIL lymphoblasts and primary T-cell acute lymphoblastic leukemias
Karen VerboomiD, Wouter Van LoockeiD, Emmanuelle ClappieriD, Jean SoulieriD, Jo VandesompeleiD, Frank SpelemaniD, Kaat DurinckiD
Abstract
Most currently available transcriptome data of T-cell acute lymphoblastic leukemia (T-ALL) are based on polyA[+] RNA sequencing methods thus lacking non-polyadenylated transcripts. Here, we present the data of polyA[+] and total RNA sequencing in the context of in vitro TLX1 knockdown in ALL-SIL cells and a primary T-ALL cohort. We extended this dataset with ATAC sequencing and H3K4me1 and H3K4me3 ChIP sequencing data to map putative gene regulatory regions. In this data descriptor, we present a detailed report of how the data were generated and which bioinformatics analyses were performed. Through several technical validations, we showed that our sequencing data are of high quality and that our in vitro TLX1 knockdown was successful. We also validated the quality of the ATAC and ChIP sequencing data and showed that ATAC and H3K4me3 ChIP peaks are enriched at transcription start sites. We believe that this comprehensive set of sequencing data can be reused by others to further unravel the complex biology of T-ALL in general and TLX1 in particular.
- organism: human
- assay: bulk RNA-seq
- assay: ATAC-seq
- assay: ChIP-seq
- research focus: database / resource
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TALLSorts: a T-cell acute lymphoblastic leukaemia subtype classifier using RNA-seq expression data
Allen Gu, Breon Schmidt, … Alicia Oshlack·Blood AdvancesPeer-reviewed·Oct 30, 2023
- Role of Stem-Like Cells in Chemotherapy Resistance and Relapse in pediatric T Cell Acute Lymphoblastic Leukemia
Julia Costea, Kerstin Katharina Rauwolf, … Jan O. Korbel·Nature CommunicationsPeer-reviewed·Jun 27, 2025
- Therapeutic targeting of ACLY in T-ALL in vivo
V. da Silva-Diz, A. Singh, … D. Herranz·bioRxiv·Mar 27, 2023
- 3D Genome Analysis Identifies Enhancer Hijacking Mechanism for High-Risk Factors in Human T-Lineage Acute Lymphoblastic Leukemia
Lu Yang, Fengling Chen, … Hong Wu·bioRxiv·Mar 11, 2020
- Mining single-cell transcriptomic data reveals distinct T-cell population in pediatric B-ALL and AML at diagnosis
Liqing Tian, Stephen M Gottschalk·Blood AdvancesPeer-reviewed·Apr 14, 2026
- Integrated Genomic Analyses Identify High-Risk Factors and Actionable Targets in T-Cell Acute Lymphoblastic Leukemia
Haichuan Zhu, Bingjie Dong, … Hong Wu·Blood SciencePeer-reviewed·Jan 1, 2022